Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
Open Access
- 24 June 2010
- Vol. 116 (20), 4777-4787
- https://doi.org/10.1002/cncr.25292
Abstract
BACKGROUND: A study was undertaken to analyze the survival of chronic lymphocytic leukemia (CLL) patients relative to age‐matched individuals in the general population and determine the age‐stratified utility of prognostic testing. METHODS: All 2487 patients diagnosed with CLL between January 1995 and June 2008 and cared for in the Mayo Clinic Division of Hematology were categorized by age at diagnosis and evaluated for differences in clinical characteristics, time to first treatment, and overall survival (OS). RESULTS: Among Rai stage 0 patients, survival was shorter than the age‐matched general population for patients aged P < .001), 55 to 64 years (P < .001), and 65 to 74 years (P < .001), but not those aged ≥75 years at diagnosis (P = not significant). CD38, IGHV mutation, and ZAP‐70 each predicted time to first treatment independent of stage for all age groups (all P < .04), but had less value for predicting OS, particularly as age increased. IGHV and fluorescent in situ hybridization (FISH) predicted OS independent of stage for patients aged P ≤ .001), 55 to 64 years (P ≤ .004), and 65 to 74 years (P ≤ .001), but not those aged ≥75 years. CD38 and ZAP‐70 each predicted OS independent of stage for only 2 of 4 age categories. Among Rai 0 patients aged IGHV unmutated (P < .001) patients or those with unfavorable FISH (P < .001). CONCLUSIONS: Survival of CLL patients aged IGHV or stage and FISH identifies those with excess risk of death relative to the age‐matched population. Although useful for predicting time to first treatment independent of stage for patients of all ages, prognostic testing had little utility for predicting OS independent of stage among patients aged ≥75 years. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 51 references indexed in Scilit:
- Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in SwedenHaematologica, 2009
- B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcomeBlood, 2009
- Validation of a new prognostic index for patients with chronic lymphocytic leukemiaCancer, 2008
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaBlood, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaBritish Journal of Haematology, 2008
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Variation in survival of adult patients with haematological malignancies in Europe since 1978European Journal of Cancer, 1998
- Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survivalBritish Journal of Haematology, 1989